Answers are grounded in this paper and cite their sources.
Retrospective cohort shows peripheral artery disease linked to higher amputation risk in diabetic foot ulcers, highlighting care gaps.
Diabetic foot ulcers (DFUs) complicated by peripheral artery disease (PAD) carry a high limb-loss risk. In Saudi Arabia, inconsistent ischemia assessment and delayed revascularization may worsen outcomes. We assessed PAD prevalence, ischemia severity, outcomes, and care gaps in tertiary DFU admissions. Retrospective multicenter cohort (January 2020–December 2022) across three tertiary vascular centers. Adults with diabetes and DFU were included; prior ipsilateral revascularization and non-salvageable limbs were excluded. PAD was defined using ABI (<0.90) and/or duplex/CTA/MRA evidence of stenosis/occlusion. Toe-pressure/toe-brachial index (TP/TBI) values were recorded for all patients, but were not used as part of a standardized reflex pathway with consistent timing prior to index management decisions. Outcomes were index major amputation, limb salvage, and 12-month major amputation-free survival (AFS). Among 229 patients, 43 (18.8%) had PAD. PAD patients had more comorbidities and advanced tissue loss; ABI was 0.60±0.17 vs 1.12±0.21 in non-PAD (p<0.001). Debridement was less frequent in PAD (58.1% vs 87.1%; p<0.001). Major amputation occurred in 48.8% vs 14.5% (p<0.001), and limb salvage was 51.2% vs 85.5% (p<0.001). No PAD patient underwent pre-debridement or in-admission revascularization. Twelve-month AFS was 0.513 vs 0.855 (HR 3.35; 95% CI 2.08–5.40; p<0.001). Nearly half of PAD limbs were approximately WIfI stages 3–4. PAD was common in tertiary DFU care, linked to major amputation and poor limb survival. The non-routine TP/TBI use prior to decisions, and 0% revascularization on admission, indicate a care gap. Toe perfusion tests, risk stratification, duplex imaging, and revascularization before debridement are recommended. • PAD is present in 18.8% of DFU admissions. • PAD is associated with a 3-fold higher amputation risk. • No ischemia, first revascularization was performed. • WIfI stages 3–4 concentrated in PAD limbs. • Toe perfusion testing and WIfI should be routine.
No takes yet. Share an insight, caveat, or question.
Alem et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: